HemoClear B.V.
PrivateLast Round
Early Funding
Jul 8, 2024
Momentum
Top 25%
of companies Caplight tracks
Company Overview
HemoClear B.V. operates in Healthcare & Life Sciences and is based in Zwolle. Its latest recorded funding round was a Grant round in June 2020.
HemoClear B.V. is a medical device company that develops and manufactures innovative microfiltration technology for autologous blood transfusion.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HemoClear B.V. Comparables
Compare HemoClear B.V. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| i-SEP | 85% | |
| Lindis Blood Care GmbH | 84% | |
| Sisu Global Health | 78% |
For institutional investors. Book with your work email.
HemoClear B.V. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jul 8, 2024 | ||||
| Grant | Jun 13, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
HemoClear B.V. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EIT Health | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 74% MoM.
- Apr 16, 2026
Monthly visitors increased 221% MoM, reaching 3.1K.
For institutional investors. Book with your work email.
HemoClear B.V. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about HemoClear B.V.'s valuation, stock price, and market status.
Is HemoClear B.V. a public or private company?
HemoClear B.V. is a private company.
What is the current stock price of HemoClear B.V.?
HemoClear B.V. is a private company, so its shares have no public market price. Caplight tracks HemoClear B.V.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is HemoClear B.V. worth (valuation)?
Valuation information for HemoClear B.V. is not publicly available.
Can I buy HemoClear B.V. stock?
HemoClear B.V. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was HemoClear B.V.'s last funding round?
HemoClear B.V.'s most recent funding round was Early Funding on July 8, 2024.
Who are the main investors in HemoClear B.V.?
Key investors in HemoClear B.V. include EIT Health.
Will HemoClear B.V. IPO soon?
No public IPO plans have been announced for HemoClear B.V..
How can I track HemoClear B.V. secondary market activity?
Caplight tracks bids, offers, and trades in HemoClear B.V.'s shares on secondary markets.